Lv4
510 积分 2022-01-05 加入
Efficacy and effectiveness of omalizumab in the treatment of childhood asthma
5天前
已完结
Bactericidal ability of target acidic phospholipids and phagocytosis of CDC42 GTPase-mediated cytoskeletal rearrangement underlie functional conservation of CXCL12 in vertebrates
3个月前
已完结
Cdc42 promotes thyroid cancer cell proliferation and migration and tumor‐associated macrophage polarization through the PTEN/AKT pathway
3个月前
已完结
Anti-IL-4/IL-13 for the treatment of asthma: the story so far
8个月前
已完结
Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies
8个月前
已完结
Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies
8个月前
已完结
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial
8个月前
已完结
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
8个月前
已完结
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study
8个月前
已完结
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
9个月前
已完结
皖公网安备34019202002308
